📣 VC round data is live. Check it out!
- Public Comps
- 7FIT
7FIT Valuation Multiples
Discover revenue and EBITDA valuation multiples for 7FIT and similar public comparables like Aqua Bio Technology, Giglio, BioRegenx, Webuy Global and more.
7FIT Overview
About 7FIT
7FIT SA is engaged in the operation of online supplement store. The company through its website offers a wide range of bodybuilding supplements for athletes.
Founded
N/A
HQ

Employees
8
Website
Financials (FY)
EV
$9M
Valuation Multiples
Start free trial7FIT Financials
7FIT reported last fiscal year revenue of $10M and EBITDA of $1M.
In the same fiscal year, 7FIT generated $3M in gross profit, $1M in EBITDA, and $787K in net income.
7FIT P&L
In the most recent fiscal year, 7FIT reported revenue of $10M and EBITDA of $1M.
7FIT is profitable as of last fiscal year, with gross margin of 31%, EBITDA margin of 11%, and net margin of 8%.
Financial data powered by Morningstar, Inc.
7FIT Stock Performance
7FIT has current market cap of $8M, and enterprise value of $9M.
Market Cap Evolution
7FIT's stock price is $4.69.
7FIT share price increased by 6.9% in the last 30 days, and by 132.5% in the last year.
7FIT has an EPS (earnings per share) of $0.44.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9M | $8M | 4.2% | 6.9% | 15.3% | 132.5% | $0.44 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free Trial7FIT Valuation Multiples
7FIT trades at 0.9x EV/Revenue multiple, and 8.2x EV/EBITDA.
7FIT Financial Valuation Multiples
As of May 8, 2026, 7FIT has market cap of $8M and EV of $9M.
7FIT has a P/E ratio of 10.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified 7FIT Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


7FIT Margins & Growth Rates
In the most recent fiscal year, 7FIT reported gross margin of 31%, EBITDA margin of 11%, and net margin of 8%.
7FIT Margins
7FIT Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
7FIT Operational KPIs
7FIT's revenue per employee in the last FY averaged $1.2M, while opex per employee averaged $0.2M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
7FIT Competitors
7FIT competitors include Aqua Bio Technology, Giglio, BioRegenx, Webuy Global, Refine Group, Arctic Bioscience, PMGC Holdings, Pharmena, NUTEX and Kumulus Vape.
Most 7FIT public comparables operate across Consumer E-commerce, Nutraceuticals & Cosmeceuticals, Vertical E-commerce and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 138.1x | — | (32.3x) | — | |||
| 0.1x | — | (54.4x) | — | |||
| 5.9x | — | (9.3x) | — | |||
| 0.4x | — | (2.0x) | — | |||
| 0.4x | — | 0.8x | — | |||
| 3.3x | — | (3.6x) | — | |||
| 10.8x | — | (0.9x) | — | |||
| 19.7x | — | (11.9x) | — | |||
This data is available for Pro users. Sign up to see all 7FIT competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout 7FIT
| Where is 7FIT headquartered? | 7FIT is headquartered in Poland. |
| How many employees does 7FIT have? | As of today, 7FIT has over 8 employees. |
| Is 7FIT publicly listed? | Yes, 7FIT is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of 7FIT? | 7FIT trades under 7FT ticker. |
| When did 7FIT go public? | 7FIT went public in 2012. |
| Who are competitors of 7FIT? | 7FIT main competitors include Aqua Bio Technology, Giglio, BioRegenx, Webuy Global, Refine Group, Arctic Bioscience, PMGC Holdings, Pharmena, NUTEX, Kumulus Vape. |
| What is the current market cap of 7FIT? | 7FIT's current market cap is $8M. |
| What is the current revenue of 7FIT? | 7FIT's last fiscal year revenue is $10M. |
| What is the current EV/Revenue multiple of 7FIT? | Current revenue multiple of 7FIT is 0.9x. |
| Is 7FIT profitable? | No, 7FIT is not profitable. |
| How many companies 7FIT has acquired to date? | 7FIT hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies 7FIT has invested to date? | 7FIT hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to 7FIT
Lists including 7FIT
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.